Cell and Gene Therapy Preclinical Development
Solutions From a Trusted and Experienced Partner
Transform your development by leveraging over 20 years of experience in advanced therapies. Read the case study to see how end-to-end support including CMC refinement with GLP, GMP and GCP testing moved this biologic to the clinic. Find out more about our cell and gene therapy clinical development solutions.
End-to-end support included CMC refinement with GLP, GMP and GCP testing to move this product to the clinic. A complex trial network involved 25 referral sites and a multi-study approach. The impact: advancement of a therapy with the potential to significantly improve the quality-of-life for people living with a rare retinal disease.
If you would like to find out more about how our team at Covance can help in your therapeutic’s development across pre-clinical, clinical and post-approval phases, get in touch by filling out the form below: